ArticleTurk gogus kalp damar cerrahisi dergisi2026
The impact of vasoactive inotropic score values on mortality and ECMO-related complications in children.
Article in Turk gogus kalp damar cerrahisi dergisi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Extracorporeal membrane oxygenation (ECMO) provides life-saving support but carries considerable risks, particularly in neonates and postcardiotomy patients. The vasoactive inotropic score (VIS), which measures cardiovascular support, shows potential as a prognostic marker; however, its role in ECMO remains underexplored. This study aims to assess the impact of vasoactive inotropic score values on mortality and ECMO-related complications in patients undergoing ECMO due to cardiopulmonary failure. Methods: We analyzed 106 pediatric patients who underwent ECMO between January 2011 and January 2021. The demographics, ECMO indications, cannulation strategies, VIS at initiation, complications, and outcomes were reviewed. The primary endpoint was in-hospital mortality. ROC curve analysis and multivariate logistic regression evaluated the prognostic utility of VIS and ECMO-related complications. Results: The in-hospital mortality rate was 57.5%, which was higher among neonates (78.6%), infants (62.0%), and patients who underwent central VA ECMO. VIS at cannulation was independently associated with mortality in multivariate analysis (median VIS: 28 in non-survivors Conclusion: A VIS score ≥28 at ECMO initiation strongly predicted in-hospital mortality. Renal complications substantially worsen clinical outcomes. Incorporating VIS into risk stratification protocols and implementing strategies to prevent major complications may improve prognosis of pediatric patients on ECMO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.